Annual EBIT
-$106.57 M
+$55.65 M+34.30%
December 31, 2023
Summary
- As of February 7, 2025, TSHA annual earnings before interest & taxes is -$106.57 million, with the most recent change of +$55.65 million (+34.30%) on December 31, 2023.
- During the last 3 years, TSHA annual EBIT has fallen by -$46.59 million (-77.66%).
- TSHA annual EBIT is now -77.66% below its all-time high of -$59.98 million, reached on December 31, 2020.
Performance
TSHA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$25.50 M
-$4.60 M-22.00%
September 30, 2024
Summary
- As of February 7, 2025, TSHA quarterly earnings before interest & taxes is -$25.50 million, with the most recent change of -$4.60 million (-22.00%) on September 30, 2024.
- Over the past year, TSHA quarterly EBIT has increased by +$90.12 million (+77.94%).
- TSHA quarterly EBIT is now -152.63% below its all-time high of $48.45 million, reached on December 31, 2023.
Performance
TSHA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$21.98 M
+$90.12 M+80.39%
September 30, 2024
Summary
- As of February 7, 2025, TSHA TTM earnings before interest & taxes is -$21.98 million, with the most recent change of +$90.12 million (+80.39%) on September 30, 2024.
- Over the past year, TSHA TTM EBIT has increased by +$186.82 million (+89.47%).
- TSHA TTM EBIT is now -1871.21% below its all-time high of -$1.11 million, reached on December 1, 2019.
Performance
TSHA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TSHA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.3% | +77.9% | +89.5% |
| 3 y3 years | -77.7% | +49.6% | +84.5% |
| 5 y5 years | - | -2187.0% | -1871.2% |
TSHA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.4% | -152.6% | +77.9% | at high | +89.5% |
| 5 y | 5-year | -77.7% | +38.4% | -152.6% | +77.9% | -1871.2% | +89.5% |
| alltime | all time | -77.7% | +38.4% | -152.6% | +77.9% | -1871.2% | +89.5% |
Taysha Gene Therapies EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$25.50 M(+22.0%) | -$21.98 M(-80.4%) |
| Jun 2024 | - | -$20.90 M(-13.0%) | -$112.09 M(-2.0%) |
| Mar 2024 | - | -$24.03 M(-149.6%) | -$114.35 M(+7.3%) |
| Dec 2023 | -$106.57 M(-34.3%) | $48.45 M(-141.9%) | -$106.57 M(-49.0%) |
| Sep 2023 | - | -$115.62 M(+399.2%) | -$208.79 M(+76.0%) |
| Jun 2023 | - | -$23.16 M(+42.5%) | -$118.63 M(-7.9%) |
| Mar 2023 | - | -$16.25 M(-69.8%) | -$128.82 M(-20.6%) |
| Dec 2022 | -$162.22 M | -$53.77 M(+111.3%) | -$162.22 M(+2.6%) |
| Sep 2022 | - | -$25.45 M(-23.7%) | -$158.14 M(-13.7%) |
| Jun 2022 | - | -$33.35 M(-32.8%) | -$183.33 M(-3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$49.65 M(-0.1%) | -$190.72 M(+10.2%) |
| Dec 2021 | -$173.09 M(+188.6%) | -$49.70 M(-1.9%) | -$173.09 M(+22.1%) |
| Sep 2021 | - | -$50.64 M(+24.3%) | -$141.72 M(+33.6%) |
| Jun 2021 | - | -$40.73 M(+27.2%) | -$106.11 M(+22.5%) |
| Mar 2021 | - | -$32.02 M(+74.8%) | -$86.60 M(+44.4%) |
| Dec 2020 | -$59.98 M | - | - |
| Dec 2020 | - | -$18.32 M(+21.8%) | -$59.98 M(+40.2%) |
| Sep 2020 | - | -$15.04 M(-29.1%) | -$42.78 M(+54.2%) |
| Jun 2020 | - | -$21.22 M(+292.7%) | -$27.74 M(+325.5%) |
| Mar 2020 | - | -$5.40 M(+384.7%) | -$6.52 M(+484.7%) |
| Dec 2019 | - | -$1.11 M | -$1.11 M |
FAQ
- What is Taysha Gene Therapies annual earnings before interest & taxes?
- What is the all time high annual EBIT for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual EBIT year-on-year change?
- What is Taysha Gene Therapies quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly EBIT year-on-year change?
- What is Taysha Gene Therapies TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Taysha Gene Therapies?
- What is Taysha Gene Therapies TTM EBIT year-on-year change?
What is Taysha Gene Therapies annual earnings before interest & taxes?
The current annual EBIT of TSHA is -$106.57 M
What is the all time high annual EBIT for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual earnings before interest & taxes is -$59.98 M
What is Taysha Gene Therapies annual EBIT year-on-year change?
Over the past year, TSHA annual earnings before interest & taxes has changed by +$55.65 M (+34.30%)
What is Taysha Gene Therapies quarterly earnings before interest & taxes?
The current quarterly EBIT of TSHA is -$25.50 M
What is the all time high quarterly EBIT for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly earnings before interest & taxes is $48.45 M
What is Taysha Gene Therapies quarterly EBIT year-on-year change?
Over the past year, TSHA quarterly earnings before interest & taxes has changed by +$90.12 M (+77.94%)
What is Taysha Gene Therapies TTM earnings before interest & taxes?
The current TTM EBIT of TSHA is -$21.98 M
What is the all time high TTM EBIT for Taysha Gene Therapies?
Taysha Gene Therapies all-time high TTM earnings before interest & taxes is -$1.11 M
What is Taysha Gene Therapies TTM EBIT year-on-year change?
Over the past year, TSHA TTM earnings before interest & taxes has changed by +$186.82 M (+89.47%)